US-China Biomedical Technology, Inc.: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2018)
- -$710.9K
- Total Assets (FY2018)
- $77.5K
- Total Equity (FY2018)
- $1.4K
- Cash Flows from Operating Activities (FY2018)
- -$544.7K
Source: US-China Biomedical Technology, Inc. 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
